$DYN
Dyne Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA
DYN chart
What traders are saying about $DYN
Latest postsDyne Therapeutics, Inc. news
- Why DYN Shares Are Down 10% After-Hours? Day After An FDA Win, Another Announcement Rocks Stock
Stocktwits ·
- Dyne Therapeutics, Inc. Estimates – NASDAQ:DYN
TradingView ·
- Form 4 Dyne Therapeutics Inc: Douglas Kerr (Head of R&D and CMO) For: 20 October
Investing.com Canada ·
- Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Top 4 Healthcare Stocks Backed by Raymond James Analysts
Yahoo Finance ·
- Why Dyne Therapeutics (DYN) Is Back In The Spotlight
Yahoo Finance ·
- Dyne Therapeutics stock rises on positive DM1 trial results
Yahoo Finance ·
- Dyne Therapeutics Announces Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
Yahoo Finance ·
- Do Dyne Therapeutics’ (DYN) Expanded DM1 Data Presentations Redefine Its Rare-Disease Investment Narrative?
Yahoo Finance ·
- Wall Street Weighs Impact On DYN Stock Post Novartis’ Phase 3 Failure — RBC Says These Key Differences Could Lead To Better Outcomes
stocktwits.com ·
- Dyne Therapeutics Myotonic Dystrophy Approach Remains Differentiated, RBC Says
Yahoo Finance ·
- Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls
Yahoo Finance ·
Dyne Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$446.2 | -$317.4 | -$235.9 | -$168.1 |
| Diluted EPS | $-3.47 | $-3.37 | $-3.95 | $-3.23 |
| Total assets (year end) | $1.19B | $691.2M | $165.1M | $306.3M |
| Cash and equivalents (year end) | $893.4M | $435.4M | $121.6M | $172.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Dyne Therapeutics, Inc.
- Ticker
- DYN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1818794
Frequently asked questions
What exchange is Dyne Therapeutics, Inc. listed on?
Dyne Therapeutics, Inc. trades on the Nasdaq under the ticker symbol DYN.
What industry is Dyne Therapeutics, Inc. in?
Dyne Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Dyne Therapeutics, Inc. headquartered?
Dyne Therapeutics, Inc.'s business address on file with the SEC is in Waltham, MA.
When does Dyne Therapeutics, Inc.'s fiscal year end?
Dyne Therapeutics, Inc.'s fiscal year ends on December 31.